TTD_Target_ID	Target_Name	TTD_Drug_ID	Drug_Name	Drug_Highest_Status	Drug_PubchemID	Molecular_Formula	Molecular_Weight	Canonical_SMILES	Activity	Binder_Type
T41580	Adrenergic receptor alpha-2B	D0OJ4L	Hydroxychloroquine	Approved	3652	C18H26ClN3O	335.9	CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO	Ki = 72443.6 nM	Poor binder
T41580	Adrenergic receptor alpha-2B	B4N8MG	2-[1-(2-Methylsulfonylphenoxy)ethyl]-4,5-dihydro-1H-imidazole	Investigative	57400959	C12H16N2O3S	268.33	CC(C1=NCCN1)OC2=CC=CC=C2S(=O)(=O)C	Ki = 51286.14 nM	Poor binder
T41580	Adrenergic receptor alpha-2B	BJDT18	2-[(1R)-1-(2-Phenylphenoxy)ethyl]-4,5-dihydro-1H-imidazole	Investigative	11043720	C17H18N2O	266.34	C[C@H](C1=NCCN1)OC2=CC=CC=C2C3=CC=CC=C3	EC50 = 100000 nM	Poor binder
T41580	Adrenergic receptor alpha-2B	BM2WG1	2-(1-(2-Methoxyphenoxy)ethyl)-4,5-dihydro-1H-imidazole	Investigative	57402717	C12H16N2O2	220.27	CC(C1=NCCN1)OC2=CC=CC=C2OC	EC50 = 100000 nM	Poor binder
T41580	Adrenergic receptor alpha-2B	BU56EC	N-(5-Bromoquinoxalin-6-yl)-4,5-dihydro-1,3-oxazol-2-amine	Investigative	44312198	C11H9BrN4O	293.12	C1COC(=N1)NC2=C(C3=NC=CN=C3C=C2)Br	Ki = 85113.8 nM	Poor binder